EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study

Leonid Feldman, Ramzia Abu Hamad, Shai Efrati, Ali Ashker, Ilia Beberashvili, Michal Shani

ISRN Nephrology · 2013

DOI: 10.5402/2013/636208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Nephrology, 2013. Verfasst von Leonid Feldman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel ; Sackler Faculty of Medicine, Tel Aviv Univ…. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Teva Pharmaceutical Industries.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preservation of residual renal function in chronic dialysis patients has proven to be a major predictor of survival. The aim of the present study was to investigate an ability of the combined use of N-acetylcysteine and high-flux biocompatible haemodialysis membranes to improve residual renal function in haemodialysis patients. Patients and Methods . Chronic haemodialysis patients with a residual urine output of at least 100 mL/24 h were administered oral an N-acetylcysteine 1200 mg twice daily for 2 weeks. Treatment group included patients treated with dialysers using high-flux synthetic biocompatible membranes. Control group included patients treated with dialysers using low-flux semisyntetic triacetate haemodialysis membranes.

Results

Eighteen patients participated in the study. The residual glomerular filtration rate showed a nonsignificant trend for increase in both groups. The magnitude of GFR improvement after N-acetylcysteine administration was less pronounced in the group treated with high-flux biocompatible membranes: +0.17 ± 0.56 mL/min/1.73 m 2 in treatment group and +0.65 ± 0.53 mL/min/1.73 m 2 in control group ( P < 0.05 ).

Conclusion

In this study of favorable effect of N-acetylcysteine on residual renal function in chronic haemodialysis patients may be less pronounced when using high-flux biocompatible, rather than low-flux semisyntetic, HD membranes.

Autor:innen und Institutionen

  • Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel ; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
  • Family Medicine Department, Clalit Health Services and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 97904, Israel.

Förderung

  • Teva Pharmaceutical Industries

Zitieren

APA

Feldman, L., Abu Hamad, R., Efrati, S., Ashker, A., Beberashvili, I., & Shani, M. (2013). Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study. ISRN Nephrology. https://doi.org/10.5402/2013/636208

Vancouver

Feldman L, Abu Hamad R, Efrati S, Ashker A, Beberashvili I, Shani M. Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study. ISRN Nephrology. 2013. doi:10.5402/2013/636208

BibTeX
@article{Feldman2013,
  author = {Feldman, Leonid and Abu Hamad, Ramzia and Efrati, Shai and Ashker, Ali and Beberashvili, Ilia and Shani, Michal},
  title = {Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study},
  journal = {ISRN Nephrology},
  year = {2013},
  doi = {10.5402/2013/636208}
}
Kostenlos starten →